Recent Updates
Recently added Catalysts
BLTE Positive Sentiment Score: 75/100

Belite Bio to Participate in the H.C. Wainwright Annual Ophthalmology Virtual Conference

Wednesday, August 6, 2025 1 min read
Key Takeaway: Belite Bio, Inc. announced its planned participation in the H.C. Wainwright Annual Ophthalmology Virtual Conference. The company's executive management team will engage in a panel discussion and present corporate information on August 13, 2025. The conference will include a focus on pivotal-stage assets related to retinal disorders, showcasing Belite's commitment to developing therapeutics for these unmet medical needs. Webcast links for the presentations will be available on their investor relations website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Belite Bio is actively advancing its clinical-stage drug development.
  • Participation in a prominent conference highlights the company's focus on retinal diseases.
  • The event offers a platform for sharing insights on pivotal-stage assets.

Full Press Release Details

SAN DIEGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the executive management team will participate in a panel discussion and corporate presentation at the H.C. Wainwright Annual Ophthalmology Virtual Conference on August 13, 2025. Details of the presentations are as follows:
7:00 am ET, on-demand corporate presentation
11:00 am ET, “Pivotal-Stage Assets for Retinal Disorders” panel discussion
Webcast Link Instructions
A webcast of each presentation can be accessed under the "Events" tab on the investor relations section of the Belite Bio website at: https://investors.belitebio.com/presentations-events/events. The replays will be archived for 90 days following the presentation date.
Media and Investor Relations Contact:
belite@argotpartners.com

Frequently Asked Questions

When will Belite Bio's corporate presentation occur?

The corporate presentation will take place on August 13, 2025, at 7:00 am ET.

What is the focus of Belite Bio, Inc.?

Belite Bio focuses on developing therapies for degenerative retinal diseases.

Where can I access the webcast of the presentations?

Webcasts are available under the 'Events' tab on Belite Bio's investor relations website.

How long will the presentation replays be available?

Replays of the presentations will be archived for 90 days after the event.

What time is the panel discussion on retinal disorders?

The panel discussion is scheduled for 11:00 am ET on August 13, 2025.

Tags: BLTE Viatris Investor Conferences Healthcare Belite Bio retinal diseases H.C. Wainwright clinical-stage
Last updated: Aug 6, 2025